These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11005048)

  • 1. Post-ECT agitation and plasma lactate concentrations.
    Auriacombe M; Rénéric JP; Usandizaga D; Gomez F; Combourieu I; Tignol J
    J ECT; 2000 Sep; 16(3):263-7. PubMed ID: 11005048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-electroconvulsive therapy agitation with etomidate.
    Freeman SA
    J ECT; 2009 Jun; 25(2):133-4. PubMed ID: 19494736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive therapy emergence agitation and succinylcholine dose.
    Swartz CM
    J Nerv Ment Dis; 1990 Jul; 178(7):455-7. PubMed ID: 2366059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECT emergence agitation and methohexital-succinylcholine interaction. Case report.
    Swartz CM
    Gen Hosp Psychiatry; 1993 Sep; 15(5):339-41. PubMed ID: 8307349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspiration and postictal agitation after electroconvulsive therapy with propofol but no succinylcholine or atropinic agent.
    Swartz CM
    J ECT; 2005 Mar; 21(1):50-1. PubMed ID: 15791180
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal.
    Bryson EO; Aloysi AS; Popeo DM; Bodian CA; Pasculli RM; Briggs MC; Kellner CH
    J ECT; 2012 Sep; 28(3):e29-30. PubMed ID: 22914634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anesthesia for electroconvulsive therapy: clinical experience].
    González AG; Cortínez LI; De la Cuadra JC; Carrasco E; Rioseco A; Léniz P
    Rev Esp Anestesiol Reanim; 2007; 54(7):414-20. PubMed ID: 17953335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series.
    Vishne T; Amiaz R; Grunhaus L
    J ECT; 2005 Jun; 21(2):118-21. PubMed ID: 15905755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe bradycardia after anesthesia before electroconvulsive therapy.
    Birkenhäger TK; Pluijms EM; Groenland TH; van den Broek WW
    J ECT; 2010 Mar; 26(1):53-4. PubMed ID: 19710620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedural complications of electroconvulsive therapy: assessment and recommendations.
    Lippmann S; Haas S; Quast G
    South Med J; 1993 Oct; 86(10):1110-4. PubMed ID: 8211326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postictal ventricular tachycardia after electroconvulsive therapy treatment associated with a lithium-duloxetine combination.
    Heinz B; Lorenzo P; Markus R; Holger H; Beatrix R; Erich S; Alain B
    J ECT; 2013 Sep; 29(3):e33-5. PubMed ID: 23670028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological response to ECT stimulus dose.
    Swartz CM
    Psychiatry Res; 2000 Dec; 97(2-3):229-35. PubMed ID: 11166093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
    Mirzakhani H; Guchelaar HJ; Welch CA; Cusin C; Doran ME; MacDonald TO; Bittner EA; Eikermann M; Nozari A
    Anesth Analg; 2016 Sep; 123(3):587-96. PubMed ID: 26967896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy.
    Vaidya PV; Anderson EL; Bobb A; Pulia K; Jayaram G; Reti I
    J ECT; 2012 Mar; 28(1):14-9. PubMed ID: 22330701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
    Acharya D; Harper DG; Achtyes ED; Seiner SJ; Mahdasian JA; Nykamp LJ; Adkison L; Van der Schuur White L; McClintock SM; Ujkaj M; Davidoff DA; Forester BP
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):265-73. PubMed ID: 24838521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.